MediWound Reports Second Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to MediWound Reports Second Quarter 2019 Financial Results

MediWound (MDWD) Tops Q2 EPS by 35c, Revenues Beat

August 13, 2019 7:02 AM EDT

MediWound (NASDAQ: MDWD) reported Q2 EPS of $0.32, $0.35 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $4.45 million.

Business and Financial Highlights for the Second Quarter 2019 and Recent Weeks include:

Total revenues for the second quarter of 2019 were $20.7 million, driven primarily by $17.5 million upfront payment from Vericel for the NexoBrid license; As of June 30, 2019, the Company had $38.7 million in cash and short-term investments, compared to $23.6 million as of December 31, 2018; Entered into an exclusive commercial license and supply agreement with... More